Donor and unrelated donor marrow unrelated donor. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy23

Bone Marrow Bone Marrow Cells Antilymphocyte Serum Hematopoietic Stem Cells T-Lymphocytes Fetal Blood Allografts Transplants Cells, Cultured Neutrophils Philadelphia Chromosome Killer Cells, Natural Spleen Stromal Cells Granulocytes Lymphocytes Cell Line Liver Clone Cells Stem Cells Megakaryocytes Thymus Gland Blood Cells

Organisms9

Transplantation Chimera Radiation Chimera Mice, Inbred C57BL Cytomegalovirus Mice, Inbred BALB C Chimera Mice, Knockout Mice, Inbred Strains Mice, Transgenic

Diseases38

Graft vs Host Disease Hematologic Neoplasms Leukemia Recurrence Anemia, Aplastic Precursor Cell Lymphoblastic Leukemia-Lymphoma Leukemia, Myelogenous, Chronic, BCR-ABL Positive Hematologic Diseases Myelodysplastic Syndromes Acute Disease Leukemia, Myeloid, Acute Histiocytosis, Non-Langerhans-Cell Infection Severe Combined Immunodeficiency Bone Marrow Diseases Wiskott-Aldrich Syndrome Cytomegalovirus Infections Fanconi Anemia Metabolism, Inborn Errors Cadaver Anemia, Refractory, with Excess of Blasts Leukemia, Myeloid Leukemia, Myelomonocytic, Acute Chronic Disease Bone Marrow Neoplasms Lymphoproliferative Disorders Immunologic Deficiency Syndromes Lymphoma Genetic Diseases, Inborn Hepatic Veno-Occlusive Disease Philadelphia Chromosome Multiple Myeloma Neoplasm, Residual Opportunistic Infections Lymphoma, Non-Hodgkin Brain Death Neoplasm Recurrence, Local Pancytopenia

Chemicals and Drugs35

HLA Antigens Immunosuppressive Agents Antilymphocyte Serum Vidarabine Myeloablative Agonists HLA-DP beta-Chains Busulfan HLA-DP Antigens HLA-A Antigens Cyclosporine Methotrexate HLA-B Antigens Tacrolimus HLA-C Antigens Cyclophosphamide Melphalan HLA-DRB1 Chains HLA-DR Antigens Mycophenolic Acid Antibodies, Neoplasm Granulocyte Colony-Stimulating Factor Methylprednisolone Antigens, CD34 Receptors, KIR Antibodies, Monoclonal Thiotepa HLA-DQ Antigens Cytarabine Histocompatibility Antigens Class I Antineoplastic Agents Antibodies, Monoclonal, Humanized RNA, Messenger Recombinant Proteins Antigens, CD DNA

Analytical, Diagnostic and Therapeutic Techniques and Equipment73

Bone Marrow Transplantation Histocompatibility Testing Transplantation, Homologous Transplantation Conditioning Hematopoietic Stem Cell Transplantation Cord Blood Stem Cell Transplantation Whole-Body Irradiation Lymphocyte Depletion Treatment Outcome Survival Analysis Peripheral Blood Stem Cell Transplantation Donor Selection Disease-Free Survival Retrospective Studies Leukocyte Transfusion Survival Rate Hemibody Irradiation Remission Induction Stem Cell Transplantation Life Tables Actuarial Analysis Transplantation, Autologous Kidney Transplantation Follow-Up Studies Registries Immunosuppression Cause of Death Risk Factors Bone Marrow Examination Lymphocyte Transfusion Transplantation, Isogeneic Incidence Blood Cell Count Prognosis Polymerase Chain Reaction Hematopoietic Stem Cell Mobilization Combined Modality Therapy Leukocyte Count Salvage Therapy Liver Transplantation Bone Marrow Purging Prospective Studies Multivariate Analysis Blood Preservation Lymphocyte Count Proportional Hazards Models Kaplan-Meier Estimate Platelet Count Colony-Forming Units Assay Tissue and Organ Harvesting Cohort Studies Antineoplastic Combined Chemotherapy Protocols Fatal Outcome Risk Flow Cytometry Treatment Failure Probability Pedigree Insemination, Artificial, Heterologous Drug Therapy, Combination Feasibility Studies Cell Separation Blood Transfusion Oocyte Donation Immunophenotyping Skin Transplantation DNA Mutational Analysis Heart Transplantation Cell Count Organ Preservation Organ Transplantation Lymphocyte Activation Reverse Transcriptase Polymerase Chain Reaction

Psychiatry and Psychology3

Siblings Nuclear Family Family

Phenomena and Processes36

Histocompatibility Graft Survival Host vs Graft Reaction Radiation Chimera Graft Rejection Transplantation Immunology Time Factors Graft vs Tumor Effect Hematopoiesis Alleles Graft vs Leukemia Effect Blood Cell Count Chimerism Haplotypes Leukocyte Count Genotype Lymphocyte Count Philadelphia Chromosome Platelet Count Base Sequence Polymorphism, Genetic Risk Cell Differentiation Immunocompromised Host Mutation Major Histocompatibility Complex Phenotype Genes, MHC Class I Probability Amino Acid Sequence Graft vs Host Reaction Cell Division Cell Count Kinetics Lymphocyte Activation Exons

Anthropology, Education, Sociology and Social Phenomena3

Siblings Nuclear Family Family

Information Science9

Survival Rate Life Tables Registries Cause of Death Incidence Molecular Sequence Data Base Sequence Fatal Outcome Amino Acid Sequence

Named Groups6

Unrelated Donors Tissue Donors Blood Donors Living Donors Siblings Infant, Newborn

Health Care27

Treatment Outcome Survival Analysis Donor Selection Disease-Free Survival Retrospective Studies Survival Rate Tissue and Organ Procurement Directed Tissue Donation Life Tables Actuarial Analysis Follow-Up Studies Registries Cause of Death Risk Factors Incidence Prospective Studies Age Factors Multivariate Analysis Proportional Hazards Models Kaplan-Meier Estimate Cohort Studies Fatal Outcome Risk Treatment Failure Probability Feasibility Studies Blood Banks

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Bone Marrow Transplantation Unrelated Donors Histocompatibility Histocompatibility Testing Graft vs Host Disease Tissue Donors Transplantation, Homologous Transplantation Conditioning Blood Donors Living Donors Hematopoietic Stem Cell Transplantation Bone Marrow Hematologic Neoplasms Graft Survival Cord Blood Stem Cell Transplantation HLA Antigens Leukemia Whole-Body Irradiation Bone Marrow Cells Host vs Graft Reaction Lymphocyte Depletion Recurrence Transplantation Chimera Anemia, Aplastic Treatment Outcome Survival Analysis Radiation Chimera Immunosuppressive Agents Graft Rejection Antilymphocyte Serum Peripheral Blood Stem Cell Transplantation Donor Selection Vidarabine Myeloablative Agonists Disease-Free Survival Precursor Cell Lymphoblastic Leukemia-Lymphoma Siblings HLA-DP beta-Chains Busulfan Leukemia, Myelogenous, Chronic, BCR-ABL Positive Hematopoietic Stem Cells Retrospective Studies Hematologic Diseases Leukocyte Transfusion T-Lymphocytes Myelodysplastic Syndromes Survival Rate Fetal Blood Acute Disease Leukemia, Myeloid, Acute Tissue and Organ Procurement Transplantation Immunology HLA-DP Antigens Hemibody Irradiation Remission Induction HLA-A Antigens Allografts Directed Tissue Donation Stem Cell Transplantation Life Tables Time Factors Cyclosporine Mice, Inbred C57BL Actuarial Analysis Transplantation, Autologous Histiocytosis, Non-Langerhans-Cell Methotrexate Kidney Transplantation Infection HLA-B Antigens Tacrolimus HLA-C Antigens Transplants Follow-Up Studies Severe Combined Immunodeficiency Registries Cyclophosphamide Bone Marrow Diseases Wiskott-Aldrich Syndrome Immunosuppression Cytomegalovirus Infections Cause of Death Fanconi Anemia Graft vs Tumor Effect Risk Factors Hematopoiesis Melphalan Bone Marrow Examination Alleles Graft vs Leukemia Effect Metabolism, Inborn Errors HLA-DRB1 Chains Lymphocyte Transfusion Cadaver Anemia, Refractory, with Excess of Blasts Transplantation, Isogeneic Leukemia, Myeloid Leukemia, Myelomonocytic, Acute HLA-DR Antigens Incidence

No FAQ available that match "donor and unrelated donor marrow unrelated donor"